ACADIA PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 6, 2012

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - ACADIA PHARMACEUTICALS INCFinancial_Report.xls
EX-31.1 - CERTIFICATION OF ULI HACKSELL, PH.D., CHIEF EXECUTIVE OFFICER - ACADIA PHARMACEUTICALS INCd268616dex311.htm
EX-32.2 - CERTIFICATION OF THOMAS H. AASEN, CHIEF FINANCIAL OFFICER - ACADIA PHARMACEUTICALS INCd268616dex322.htm
EX-21.1 - LIST OF SUBSIDIARIES OF THE REGISTRANT - ACADIA PHARMACEUTICALS INCd268616dex211.htm
EX-32.1 - CERTIFICATION OF ULI HACKSELL, PH.D., CHIEF EXECUTIVE OFFICER - ACADIA PHARMACEUTICALS INCd268616dex321.htm
EX-31.2 - CERTIFICATION OF THOMAS H. AASEN, CHIEF FINANCIAL OFFICER - ACADIA PHARMACEUTICALS INCd268616dex312.htm
10-K - FORM 10-K - ACADIA PHARMACEUTICALS INCd268616d10k.htm
EX-10.23 - SEVENTH AMENDMENT TO COLLABORATIVE RESEARCH, DEVELOPMENT AND LICENSE AGREEMENT - ACADIA PHARMACEUTICALS INCd268616dex1023.htm

EXHIBIT 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-153347, 333-161059, 333-171722 and 333-178748) and the Registration Statements on Form S-8 (Nos. 333-115956, 333-128290, 333-137557, 333-146398, 333-153346, 333-161057, 333-168667 and 333-176212) of ACADIA Pharmaceuticals Inc. of our report dated March 6, 2012 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

/s/ PricewaterhouseCoopers LLP

PricewaterhouseCoopers LLP

San Diego, California

March 6, 2012

ACADIA PHARMACEUTICALS INC Reports